EUR 22.5
(-6.25%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 18.7 Million EUR | -7.4% |
2022 | 20.19 Million EUR | -17.31% |
2021 | 24.42 Million EUR | -10.27% |
2020 | 27.22 Million EUR | -5.69% |
2019 | 28.86 Million EUR | 8808.33% |
2018 | 324 Thousand EUR | -4.99% |
2017 | 341 Thousand EUR | -54.41% |
2016 | 748 Thousand EUR | -18.16% |
2015 | 914 Thousand EUR | -34.95% |
2014 | 1.4 Million EUR | -32.71% |
2013 | 2.08 Million EUR | -34.11% |
2012 | 3.16 Million EUR | 97.2% |
2011 | 1.6 Million EUR | -41.92% |
2010 | 2.76 Million EUR | -30.96% |
2009 | 4 Million EUR | 17.02% |
2008 | 3.42 Million EUR | 0.0% |
2005 | - EUR | -100.0% |
2004 | 389.41 Thousand EUR | 0.0% |
2003 | - EUR | 0.0% |
2002 | - EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 13.1 Million EUR | -81.48% |
2024 Q2 | 16.2 Million EUR | 376.47% |
2024 Q1 | 3.4 Million EUR | -80.4% |
2023 Q3 | 2.9 Million EUR | -9.38% |
2023 Q1 | 1.7 Million EUR | -91.58% |
2023 Q4 | 17.34 Million EUR | 498.03% |
2023 FY | 18.7 Million EUR | -7.4% |
2023 Q2 | 3.2 Million EUR | 88.24% |
2022 Q2 | 1.9 Million EUR | 26.67% |
2022 FY | 20.19 Million EUR | -17.31% |
2022 Q1 | 1.5 Million EUR | -93.86% |
2022 Q4 | 20.19 Million EUR | -9.03% |
2022 Q3 | 22.2 Million EUR | 1068.42% |
2021 Q3 | 900 Thousand EUR | 0.0% |
2021 Q2 | 900 Thousand EUR | 12.5% |
2021 Q4 | 24.42 Million EUR | 2613.78% |
2021 Q1 | 800 Thousand EUR | -97.06% |
2021 FY | 24.42 Million EUR | -10.27% |
2020 Q2 | 30 Million EUR | 1.69% |
2020 Q4 | 27.22 Million EUR | 2374.55% |
2020 FY | 27.22 Million EUR | -5.69% |
2020 Q1 | 29.5 Million EUR | 2.21% |
2020 Q3 | 1.1 Million EUR | -96.33% |
2019 FY | 28.86 Million EUR | 8808.33% |
2019 Q1 | 700 Thousand EUR | 116.05% |
2019 Q3 | 30.9 Million EUR | -3.74% |
2019 Q2 | 32.1 Million EUR | 4485.71% |
2019 Q4 | 28.86 Million EUR | -6.59% |
2018 FY | 324 Thousand EUR | -4.99% |
2018 Q3 | 300 Thousand EUR | 0.0% |
2018 Q2 | 300 Thousand EUR | 0.0% |
2018 Q1 | 300 Thousand EUR | -12.02% |
2018 Q4 | 324 Thousand EUR | 8.0% |
2017 FY | 341 Thousand EUR | -54.41% |
2017 Q4 | 341 Thousand EUR | -57.38% |
2017 Q3 | 800 Thousand EUR | 0.0% |
2017 Q2 | 800 Thousand EUR | 0.0% |
2017 Q1 | 800 Thousand EUR | 6.95% |
2016 Q2 | 800 Thousand EUR | 0.0% |
2016 Q4 | 748 Thousand EUR | 6.86% |
2016 Q3 | 700 Thousand EUR | -12.5% |
2016 Q1 | 800 Thousand EUR | -12.47% |
2016 FY | 748 Thousand EUR | -18.16% |
2015 Q4 | 914 Thousand EUR | -8.6% |
2015 Q2 | 1.1 Million EUR | -8.33% |
2015 Q3 | 1 Million EUR | -9.09% |
2015 Q1 | 1.2 Million EUR | -14.59% |
2015 FY | 914 Thousand EUR | -34.95% |
2014 Q2 | 1.9 Million EUR | -5.0% |
2014 FY | 1.4 Million EUR | -32.71% |
2014 Q3 | 1.6 Million EUR | -15.79% |
2014 Q4 | 1.4 Million EUR | -12.19% |
2014 Q1 | 2 Million EUR | -4.21% |
2013 Q1 | 2 Million EUR | -36.89% |
2013 Q3 | 1.6 Million EUR | -11.11% |
2013 Q2 | 1.8 Million EUR | -10.0% |
2013 Q4 | 2.08 Million EUR | 30.5% |
2013 FY | 2.08 Million EUR | -34.11% |
2012 FY | 3.16 Million EUR | 97.2% |
2012 Q4 | 3.16 Million EUR | 0.0% |
2012 Q1 | - EUR | -100.0% |
2012 Q2 | - EUR | 0.0% |
2012 Q3 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2011 Q3 | - EUR | 0.0% |
2011 Q4 | 1.6 Million EUR | 0.0% |
2011 FY | 1.6 Million EUR | -41.92% |
2011 Q1 | - EUR | -100.0% |
2010 FY | 2.76 Million EUR | -30.96% |
2010 Q2 | - EUR | 0.0% |
2010 Q1 | - EUR | -100.0% |
2010 Q4 | 2.76 Million EUR | 0.0% |
2010 Q3 | - EUR | 0.0% |
2009 Q4 | 4 Million EUR | 0.0% |
2009 FY | 4 Million EUR | 17.02% |
2008 FY | 3.42 Million EUR | 0.0% |
2005 FY | - EUR | -100.0% |
2004 FY | 389.41 Thousand EUR | 0.0% |
2003 FY | - EUR | 0.0% |
2002 FY | - EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Cegedim SA | 285.1 Million EUR | 93.441% |
Guerbet SA | 364.58 Million EUR | 94.871% |
Nexus AG | 20.24 Million EUR | 7.632% |
Bastide Le Confort Médical SA | 356.96 Million EUR | 94.761% |
Drägerwerk AG & Co. KGaA | 471.38 Million EUR | 96.033% |
Sartorius Aktiengesellschaft | 5.27 Billion EUR | 99.646% |
LNA Santé SA | 887.67 Million EUR | 97.893% |
Siemens Healthineers AG | 633 Million EUR | 97.046% |
Medios AG | 17.14 Million EUR | -9.051% |
Equasens Société anonyme | 69.27 Million EUR | 73.005% |
Stratec SE | 141.37 Million EUR | 86.772% |